Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.40% is 71% above its 5-year average of 0.82%, near the high end of its 5-year range (0.12%–1.76%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.10% below its 12-month average of 1.48%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.40%.
DEBT TO ASSETS RATIO
1.40%
DEBT TO ASSETS RATIO AVG TTM
1.48%
DEBT TO ASSETS RATIO AVG 3Y
0.75%
DEBT TO ASSETS RATIO AVG 5Y
0.82%
DEBT TO ASSETS RATIO AVG 10Y
0.67%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.10%
CURRENT VS 3Y AVG
+87.53%
CURRENT VS 5Y AVG
+70.81%
CURRENT VS 10Y AVG
+107.68%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 866 covered companies
CURRENT VS SECTOR MEDIAN
+1456.29%
vs the sector median at left
Kiora Pharmaceuticals, Inc.
Market Cap
$11.12M
Debt to Assets Ratio
1.40%
TTM Avg
1.48%
3Y Avg
0.75%
5Y Avg
0.82%
Market Cap
$10.96M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.30M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.92M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.50M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiora Pharmaceuticals, Inc. (KPRX) | $11.12M | 1.40% | 1.48% | 0.75% | 0.82% |
| BioVie Inc. (BIVI)vs › | $11.09M | 0.02% | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.96M | 0.00% | N/A | N/A | N/A |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.30M | 0.02% | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.94M | 0.00% | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.92M | 0.00% | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.83M | 0.00% | N/A | N/A | N/A |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.50M | 0.00% | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.60M | 0.31% | N/A | N/A | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.59M | 0.01% | N/A | N/A | N/A |
Debt/Assets
1.4%
Debt/Equity
0.02
Current Ratio
8.97
Interest Coverage
-473.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.40% |
| 2026-03-31 | 1.76% |
| 2025-12-31 | 1.52% |
| 2025-09-30 | 1.35% |
| 2025-06-30 | 1.35% |
| 2025-03-31 | 0.47% |
| 2024-12-31 | 0.16% |
| 2024-09-30 | 0.19% |
| 2024-06-30 | 0.20% |
| 2024-03-31 | 0.22% |
| 2023-12-31 | 0.78% |
| 2023-09-30 | 0.12% |
| 2023-06-30 | 0.20% |
| 2023-03-31 | 0.44% |
| 2022-12-31 | 0.57% |
| 2022-09-30 | 0.77% |
| 2022-06-30 | 1.07% |
| 2022-03-31 | 0.90% |
| 2021-12-31 | 1.04% |
| 2021-09-30 | 1.02% |
| 2021-06-30 | 1.70% |
| 2021-03-31 | 2.53% |
| 2020-12-31 | 3.75% |
| 2020-09-30 | 3.68% |
| 2020-06-30 | 3.47% |
| 2020-03-31 | 1.19% |
| 2019-12-31 | 0.83% |
| 2019-09-30 | 1.42% |
| 2019-06-30 | 1.02% |
| 2019-03-31 | 0.03% |
| 2018-12-31 | 0.03% |
| 2018-09-30 | 0.04% |
| 2018-06-30 | 0.05% |
| 2018-03-31 | 0.12% |
| 2017-12-31 | 0.11% |
| 2017-09-30 | 0.12% |
| 2017-06-30 | 0.12% |
| 2017-03-31 | 0.21% |
| 2016-12-31 | 0.30% |
| 2016-09-30 | 0.30% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 227.91% |
| 2014-09-30 | 176.58% |
| 2014-06-30 | 219.41% |
| 2014-03-31 | 367.09% |
| 2013-12-31 | 292.87% |
